Identification of novel deoxyribofuranosyl indole antimicrobial agents

[1]  I. Chopra,et al.  XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity. , 2009, The Journal of antimicrobial chemotherapy.

[2]  I. Chopra,et al.  Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus. , 2008, The Journal of antimicrobial chemotherapy.

[3]  Clinical,et al.  Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard , 2008 .

[4]  H. Sakaguchi,et al.  Stereocontrolled total synthesis of (-)-kainic acid. , 2007, Organic letters.

[5]  S. Pillai,et al.  Emergence of a Clinical Daptomycin-Resistant Staphylococcus aureus Isolate during Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis , 2006, Journal of Clinical Microbiology.

[6]  R. Moellering.  Vancomycin: a 50-year reassessment. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  D. Snydman,et al.  Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  B. Eisenstein,et al.  The advance of bacterididal drugs in the treatment of infection , 2004 .

[9]  C. Stratton.  Dead Bugs Don’t Mutate: Susceptibility Issues in the Emergence of Bacterial Resistance , 2003, Emerging infectious diseases.

[10]  T. Kan,et al.  Total synthesis of ecteinascidin 743. , 2002, Journal of the American Chemical Society.

[11]  Mary Jane Ferraro,et al.  Linezolid resistance in a clinical isolate of Staphylococcus aureus , 2001, The Lancet.

[12]  K. Miura,et al.  Katanosin B and Plusbacin A3, Inhibitors of Peptidoglycan Synthesis in Methicillin-ResistantStaphylococcus aureus , 2001, Antimicrobial Agents and Chemotherapy.

[13]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[14]  Yoshihisa Kobayashi,et al.  Stereocontrolled Total Synthesis of (+)-K252a , 1999 .

[15]  F. Tenover,et al.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. , 1997, The Journal of antimicrobial chemotherapy.

[16]  J. Waitz.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[17]  J. Duval,et al.  Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. , 1988, The New England journal of medicine.

[18]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[19]  R. Knox,et al.  “Celbenin” - resistant Staphylococci , 1961 .

[20]  K. Eriksen,et al.  “Celbenin”-resistant Staphylococci , 1961, Ugeskrift for laeger.

[21]  M. Jevons.  "Carbenin"-resistant Staphylococci , 1961 .

[22]  C. Rammelkamp,et al.  Resistance of Staphylococcus aureus to the Action of Penicillin.∗ , 1942 .